Show/hide contentOpenClose All
Curricular information is subject to change
Learning Outcomes:
This module is designed to help students to understand and appreciate the challenges and opportunities that the biotherapeutics industry faces in developing powerful medicines for treatment of our most difficult diseases. Students will learn:
• How are biotherapeutic molecules made
• Strategies and technologies in the development of new biotherapeutic drugs
• Technical challenges in maximising expression of biotherapeutics
• Challenges in purification of biotherapeutics
• Focus areas in the biotherapeutics industry where companies are developing new drug classes e.g., ADCs and Bispecifics
• A detailed understanding of the holistic process of developing a biotherapeutic and the multidisciplinary nature of this activity
• Recognise and utilise the skills involved in managing a group project
Student Effort Type | Hours |
---|---|
Lectures | 24 |
Tutorial | 6 |
Seminar (or Webinar) | 3 |
Autonomous Student Learning | 83 |
Total | 116 |
Not applicable to this module.
Description | Timing | Component Scale | % of Final Grade | ||
---|---|---|---|---|---|
Class Test: In class short answer quiz II | Week 11 | n/a | Graded | No | 15 |
Class Test: In class short answer quiz I | Week 6 | n/a | Graded | No | 15 |
Class Test: In class essay | Unspecified | n/a | Graded | No | 50 |
Assignment: Group poster profiling a specific biotherapeutic company. Peer to peer assessment with feedback presentation. | Week 12 | n/a | Graded | No | 20 |
Resit In | Terminal Exam |
---|---|
Summer | Yes - 2 Hour |
• Feedback individually to students, post-assessment
Invitation to meet to discuss post-assessment
Name | Role |
---|---|
Assoc Professor Siobhán McClean | Lecturer / Co-Lecturer |
Professor Keith Murphy | Lecturer / Co-Lecturer |
Dr Tanja Narancic | Lecturer / Co-Lecturer |